2016 Trending Stocks

Troublesome Estrogen Patch Shortages Hit Hard You'd think getting a prescription filled would be a simple task, right? Well, think again. Midi Health shines a glaring light on how the supposed ease of getting hormone therapy is anything but for many women in 2026. Out of those scrambling for estradiol patches, 44% hit roadblocks in pharmacies, and a third hit an all-out...

Details on Escalade's Upcoming Financial Revelation Evansville's own Escalade, Inc. (NASDAQ: ESCA) is set to drop its third quarter 2026 financial results on October 29, well before your breakfast is done. For anyone following this stock, it's like waiting for the last few seconds of a tied basketball game. This isn’t just about numbers – it’s about a whole host of...

Ignacio Esteban: A Champion in Community Finance Trust me, there's a lesson to be learned from the life of Ignacio Esteban: dedication to a cause can leave quite the ripple effect. Just ask the folks at the Opportunity Finance Network (OFN), who recently awarded him their highest honor, the 2026 Ned Gramlich Lifetime Achievement Award for Responsible Finance. Leaving a...

Cracking the Code of Small Business Finance BOB, a Miami hotshot aiming to be more than just another fintech flash in the pan, has wrangled a sweet $5.5 million in seed capital. They're shaking hands with big names like Peter Thiel and the mastermind behind Plaid, Zak Perret, through Mischief Ventures. The plan? To build an AI-powered finance savior for small businesses...

Seeing CobbleStone Software team up with Hatch Advisory feels like stumbling across an old pal leading a promising venture down the innovation road. This partnership isn't just another handshaking ceremony—it's a real shift for the tech-adoption space, especially in the contract lifecycle management (CLM) domain, where CobbleStone already has quite the footprint....

The Grind of Securing a Limited-Edition Supercar If you're grinding to buy one of those elusive limited-edition supercars, you'd better buckle up. According to Kendall Gath over at iLusso, this ain't like picking up groceries at the local market. There's a whole list of things to consider before you even think about handing over your wad of cash. Differentiating Fact from...

Bracing for the Delisting Impact Well, isn't that a familiar tune? Lunai Bioworks Inc., ticking with the symbol NASDAQ:LNAI, is pulling the plug on its Nasdaq listing faster than a kid yanking out a loose tooth. On October 21, 2026, the company's board decided it's cheaper and simpler to step off the dance floor than keep paying for a spot when the music's stopped....

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

3Srobotics Steps Into the Big League The sweltering buzz of FABTECH 2026 in Las Vegas signals more than just another industry tradeshow; it's the stage upon which 3Srobotics made its North American debut. In a span shorter than it takes most companies to get serious about their business cards, 3Srobotics has already nailed three funding rounds, snagging tens of millions...

When a company lets its tech do some of the talking, you know they're getting serious. That's exactly what's happening over at Union Home Mortgage (UHM) as they spotlight their latest tech investments at their 2026 Annual Partner Celebration in Cleveland. It was a gathering packed with over 850 employees, or as they say, Partners, fueling this momentum as they peer...

Palantir Technologies Soars with Inclusion in the S&P 500 Palantir Technologies (NYSE: PLTR) has recently seen an impressive rise in its stock prices, thanks to its inclusion in the esteemed S&P 500 index. This news sparked excitement during premarket trading, where shares jumped by over 8%. The S&P Dow Jones Indices confirmed that Palantir will officially join the index,...

Recent Advances in GSK's Nucala for COPD GSK's phase III trial of its prominent drug Nucala (mepolizumab), aimed at treating chronic obstructive pulmonary disease (COPD), has successfully achieved its primary objective. This notable milestone in COPD treatment represents a significant step forward in therapies for respiratory conditions. The groundbreaking MATINEE study...

Understanding the Legal Landscape for Five9 Investors Faruqi & Faruqi, LLP is reaching out to investors affected by potential losses related to Five9, Inc. To ensure that victims of these circumstances are informed of their legal options, the firm's Securities Litigation Partner, James (Josh) Wilson, is available for direct consultation. He urges anyone who has purchased...

Game Changer for Quantum Technology If you thought the quantum sector was crawling, buckle up. Monarch Quantum, Inc. just landed a huge gig—delivering its integrated Quantum Light Engines™ for NASA’s upcoming Quantum Gravity Gradiometer Pathfinder mission. That’s not just a feather in their cap; it’s a serious validation of their tech chops. This isn’t just...

Jim Pazzanese Appointed to Enhance Global Procurement Strategies Buyers Edge Platform (BEP), a leader in procurement, analytics, and contract management solutions dedicated to the foodservice industry, is excited to welcome Jim Pazzanese as their new Executive Vice President of Global Strategic Procurement. With a robust background spanning over 30 years in foodservice...